ESC Premium Access

A comparison of over-the-counter available smartwatches and devices for electrocardiogram based detection of atrial fibrillation

Congress Session

About the speaker

Ms Josca Scholten

Amsterdam UMC - Location Academic Medical Center, Amsterdam (Netherlands (The))
0 follower

11 more presentations in this session

The role of process mining tools in STEMI networks: where should we build a new primary PCI centre?

Speaker: Doctor J. Borges-Rosa (Coimbra, PT)

Thumbnail

Performance of a multisensory implantable cardioverter-defibrillator algorithm for remote heart failure management: the RE-HEART registry

Speaker: Doctor J. De Juan Baguda (Madrid, ES)

Thumbnail

Telerobotic interventions from a distance: an initial experience in 3D phantom mapping

Speaker: Doctor S. Ailoaei (Iasi, RO)

Thumbnail

Investigating performance of deep learning and machine learning risk stratification of Asian in-hospital patients after ST-elevation myocardial infarction.

Speaker: Doctor K. Ibrahim (Sungai Buloh, MY)

Thumbnail

Inter operator variability of machine learning researchers predicting all-cause mortality in patients admitted to intensive care unit

Speaker: Miss Y. Jones (Glasgow, GB)

Thumbnail

Access the full session

Congress committee e-posters choice in e-cardiology and digital health

Speakers: Ms J. Scholten, Doctor J. Borges-Rosa, Doctor J. De Juan Baguda, Doctor S. Ailoaei, Doctor K. Ibrahim...
Thumbnail

About the event

Image

ESC Congress 2021 - The Digital Experience

27 August - 30 August 2021

Sessions Presentations

Related content

ESC Premium Access

Renal decline in patients with atrial fibrillation treated with rivaroxaban or warfarin: a population-based cohort study in the United Kingdom

27 August 2021

ESC Premium Access

2MACE score predicts cardiovascular adverse events in real-world atrial fibrillation patients under rivaroxaban therapy. Data from EMIR study

27 August 2021

ESC Premium Access

Oral anticoagulation therapy with rivaroxaban in elderly patients with atrial fibrillation. Results from EMIR study.

27 August 2021

This platform is supported by

logo Novo Nordisk